<p><i>Size = Patient days/year; inpatient DDD = Mean defined daily doses given to inpatients per 100 patient days; hosp-spec AB = Mean defined daily doses of hospital specific antibiotics/100 patient days; in. AB = Mean defined daily doses of injectable antibiotics/100 patient days; alc-gel = Mean consumption of alcohol-based hand gels in L/1000 patient days; BC/admission = Mean number of bloodcultures per 1000 admissions.</i> A) Mean total incidence rate of blood cultures positive for S. aureus as a function of hospital size, the line represents the univariate linear model of incidence rate against hospital size B) Minimum adequate model explaining the total incidence rate C) Mean incidence rate of blood cultures positive for methici...
International audienceBackground: Antimicrobial resistance is a major threat. The prevalence of mult...
PURPOSE: The spread of multidrug-resistant bacteria is a worrisome problem worldwide. This study inv...
The PHA�coordinated Northern Ireland\u27s participation in ECDC\u27s National Prevalence Survey on�H...
<p>A) Median quarterly incidence rate of nosocomial (>48h after admission) infections as a function ...
<p>A) The proportion of potentially infectious patients among all admitted patients (log IRI) by hos...
Background: Worldwide, there is a wealth of literature examining patient-level risk 6 factors for me...
Background: Worldwide, there is a wealth of literature examining patient-level risk 6 factors for me...
<p>Prevalence of resistance in the hospital for hospitals of different sizes linked to a subdivided ...
Objective. We investigated the impact of bed occupancy, particularly overcrowding, on the incidence...
<p>The upper graphs denote the hospital-wide MRSA prevalence for different values of the isolation e...
Item does not contain fulltextOBJECTIVES: The number of defined daily doses (DDD) per 100 patient da...
<p>Incidence rate of hospital-acquired MRSA per 1000 MRSA-positive-days in three different phases of...
<p>Incidence rate of hospital-acquired MRSA per 1000 patient-days in the three phases of interventio...
<p>Data are numbers (%) of patients unless stated otherwise. Values in bold indicate factors with st...
Objectives: To estimate the transmission rate of MRSA in an intensive care unit (ICU) in an 800 bed ...
International audienceBackground: Antimicrobial resistance is a major threat. The prevalence of mult...
PURPOSE: The spread of multidrug-resistant bacteria is a worrisome problem worldwide. This study inv...
The PHA�coordinated Northern Ireland\u27s participation in ECDC\u27s National Prevalence Survey on�H...
<p>A) Median quarterly incidence rate of nosocomial (>48h after admission) infections as a function ...
<p>A) The proportion of potentially infectious patients among all admitted patients (log IRI) by hos...
Background: Worldwide, there is a wealth of literature examining patient-level risk 6 factors for me...
Background: Worldwide, there is a wealth of literature examining patient-level risk 6 factors for me...
<p>Prevalence of resistance in the hospital for hospitals of different sizes linked to a subdivided ...
Objective. We investigated the impact of bed occupancy, particularly overcrowding, on the incidence...
<p>The upper graphs denote the hospital-wide MRSA prevalence for different values of the isolation e...
Item does not contain fulltextOBJECTIVES: The number of defined daily doses (DDD) per 100 patient da...
<p>Incidence rate of hospital-acquired MRSA per 1000 MRSA-positive-days in three different phases of...
<p>Incidence rate of hospital-acquired MRSA per 1000 patient-days in the three phases of interventio...
<p>Data are numbers (%) of patients unless stated otherwise. Values in bold indicate factors with st...
Objectives: To estimate the transmission rate of MRSA in an intensive care unit (ICU) in an 800 bed ...
International audienceBackground: Antimicrobial resistance is a major threat. The prevalence of mult...
PURPOSE: The spread of multidrug-resistant bacteria is a worrisome problem worldwide. This study inv...
The PHA�coordinated Northern Ireland\u27s participation in ECDC\u27s National Prevalence Survey on�H...